Hanno Langen received his Diploma and his PhD at the University of Zürich Switzerland. After several years of a postdoctoral position in the lab of Bruce Merrifield at the Rockefeller University New York, Hanno Langen started his carrier at Hoffmann-La Roche in Basel in Switzerland. He developed the proteomics technologies as one of the first laboratories in pharmaceutical industry. Hanno Langen is one of the founding members of the human proteome organization (HUPO).
In 1995 he became group leader for proteomics in pharma research. 2000 he became the leader of the proteomics initiative of the pharmaceutical and diagnostic division of Hoffmann-La Roche.
In 2002 he received the “Privatdozent” from the University of Bern and in 2006 from the University of Basel. In 2009 Hanno Langen received the honorary professorship of the University of Basel. In 2010 he became department Head of the core competency center of Protein and Metabolite Technologies in Translational Research Sciences.
Hanno Langen is a senior editor of the Journals: Proteomics and Clinical Proteomics. Hanno Langens research is focused on the pharmaceutical and diagnostic application of proteomics in the field of Biomarker discovery and validation by using high throughput protein identification workflows.
Title of the talk:
“Proteomics in Drug Discovery: Identification and Validation the Mode of Action of Drug Targets”